Bhatia Sangeeta N.

Bhatia Sangeeta N., Director, has filed 2 insider trading reports covering 1 company. Total disclosed trading volume is $237.6K. Sales ($237.6K) outpace purchases ($0) over this period. Insider sales are common for diversification and personal financial planning and should be evaluated with full context. The largest single filing involves VERTEX PHARMACEUTICALS INC / MA (VRTX). All transactions sourced from SEC Form 4 filings.